Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Utah Medical Products (UTMD) Other Working Capital Changes (2016 - 2025)

Utah Medical Products (UTMD) has 16 years of Other Working Capital Changes data on record, last reported at $93000.0 in Q3 2025.

  • For Q3 2025, Other Working Capital Changes rose 1133.33% year-over-year to $93000.0; the TTM value through Sep 2025 reached -$61000.0, up 23.75%, while the annual FY2024 figure was $3000.0, 106.67% up from the prior year.
  • Other Working Capital Changes reached $93000.0 in Q3 2025 per UTMD's latest filing, up from -$171000.0 in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $109000.0 in Q1 2021 and bottomed at -$171000.0 in Q2 2025.
  • Average Other Working Capital Changes over 5 years is -$2421.1, with a median of $3000.0 recorded in 2021.
  • Peak YoY movement for Other Working Capital Changes: soared 1866.67% in 2022, then tumbled 700.0% in 2024.
  • A 5-year view of Other Working Capital Changes shows it stood at $3000.0 in 2021, then skyrocketed by 1866.67% to $59000.0 in 2022, then tumbled by 144.07% to -$26000.0 in 2023, then soared by 111.54% to $3000.0 in 2024, then soared by 3000.0% to $93000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Other Working Capital Changes were $93000.0 in Q3 2025, -$171000.0 in Q2 2025, and $26000.0 in Q1 2025.